Adenocarcinoma of Pancreas Clinical Trial
Official title:
Pilot Randomized Feasibility Trial Comparing Investigational Hand Therapy Intervention to Traditional Occupational Therapy Intervention to Prevent Chemotherapy-Induced Peripheral Neuropathy of the Hands in Patients Receiving Albumin Bound Paclitaxel + Gemcitabine Containing Combination Chemotherapy
A pilot randomized feasibility trial with a blinded evaluator.
Chemotherapy-induced peripheral neuropathy (CIPN) has a dose limiting effect which can greatly affect quality of life and often limits the amount of treatment patients can receive in treating their cancer. In the discipline of hand therapy, there is a science-based body of knowledge with effective protocols to treat neuropathies associated with injury and disease. These interventions have not been explored on patients with CIPN. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT01359007 -
FOLFIRINOX in Patients With Inoperable Pancreatic Cancer
|
Phase 2 |